Chapter 12: High-Risk Newborns & Neonatal Care
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
High-Risk Newborns & Neonatal Care details the complex needs of preterm infants, defined as those born before 37 weeks, distinguishing between late preterm and early term while outlining physical characteristics such as abundant vernix caseosa, lanugo, and limited subcutaneous fat. A significant portion is dedicated to respiratory pathophysiology, specifically Respiratory Distress Syndrome (RDS) caused by surfactant deficiency, the management of apnea, and the prevention of bronchopulmonary dysplasia and hypoxia through careful pulse oximetry and oxygen administration. The text explores critical nursing interventions for thermoregulation to prevent cold stress, utilizing incubators, radiant warmers, and skin-to-skin Kangaroo care. Metabolic and gastrointestinal challenges are analyzed, including hypoglycemia (blood glucose lesser than 2.6 mmol/L), hypocalcemia, and the risks of Necrotizing Enterocolitis (NEC) associated with immature digestion and ischemia. The summary further covers neurological and sensory complications like intracranial hemorrhage and Retinopathy of Prematurity (ROP). Attention is then turned to the post-term infant (born after 42 weeks), addressing risks such as Meconium Aspiration Syndrome (MAS), polycythemia, and placental insufficiency. Perinatal hematological disorders are explained, focusing on Hemolytic Disease of the Newborn (HDN) arising from Rh sensitization or ABO incompatibility, the utility of the Coombs' test, and the management of pathological hyperbilirubinemia using phototherapy and exchange transfusions to prevent kernicterus. Additional sections address Neonatal Opioid Withdrawal Syndrome (NOWS), the macrosomic infant of the diabetic mother, and the classification of birth defects, including chromosomal abnormalities like Down syndrome (Trisomy 21) and inborn errors of metabolism such as Phenylketonuria (PKU), Maple Syrup Urine Disease, and Galactosemia.